Venmax Drugs and Pharmaceuticals Ltd — Updates, 09-04-2025: Company Update

Venmax Drugs & Pharmaceuticals has submitted a compliance certificate from CIL Securities Limited, confirming adherence to regulatory requirements for the quarter and year ending March 31, 2025. This update ensures that shareholder records are accurately maintained, reflecting the company's commitment to governance standards. Although this announcement is routine, it underlines proactive compliance, potentially bolstering investor confidence. Overall, the impact is neutral, but the diligent adherence could foster a positive outlook among investors regarding management’s operational integrity.